Radiation Therapy, Symptom Monitoring
Conditions
Brief summary
This study seeks to achieve two aims: * To assess the implementation of Noona software for continuous symptom monitoring for a diverse population of patients with thoracic malignancies who are undergoing radiation and * To validate remote collection of standardized PRO measures using Noona software.
Interventions
OTHERNoona Software
Enrolled patients will be provided with login information for their Noona account. Patients will log in to the Noona symptom monitoring system using their own computer hardware. Any type of personal computer or compatible mobile device will be allowed (i.e. iPhone, Android phone). Patients will be able to access the Noona system from any internet access point and will be provided with the hospital/clinic public WiFi information.
Sponsors
Varian Medical Systems
Washington University School of Medicine
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Biopsy confirmed cancer. Radiographically apparent (i.e. not histologically or cytologically confirmed) malignancy of the thorax is allowed. * Currently planning to receive radiotherapy with or without chemotherapy for greater than one fraction. * Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable). * Age 18 years or older
Exclusion criteria
-Unable to reliably access and use a device compatible with Noona software.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of invited symptom reports completed during the study period | Treatment through 90 days of follow-up (estimated to be 5 months) |
| Percentage of questions completed within each invited symptom report | Treatment through 90 days of follow-up (estimated to be 5 months) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient reported outcomes as measured by EORTC QLQ-C30 | Baseline, within 1 week of completing therapy and at 90-day follow-up | It includes five function domains (physical, emotional, social, role, cognitive), eight symptoms (fatigue, pain, nausea/vomiting, constipation, diarrhea, insomnia, dyspnea, and appetite loss), as well as global health/quality-of-life and financial impact. Patients respond on a four-point scale from not at all to very much for most items. Most items use a past week recall period. Raw scores are linearly converted to a 0-100 scale with higher scores reflecting higher levels of function and higher levels of symptom burden. |
| Patient reported outcomes as measured by NCCN Distress Thermometer | Baseline, within 1 week of completing therapy and at 90-day follow-up | Measures distress experienced during the past week. 10 = extreme distress and 0=no distress |
Countries
United States
Outcome results
None listed